PIP4K2A
Basic information
Region (hg38): 10:22534854-22714578
Previous symbols: [ "PIP5K2A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIP4K2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 21 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 21 | 0 | 5 |
Variants in PIP4K2A
This is a list of pathogenic ClinVar variants found in the PIP4K2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-22537235-C-T | not specified | Uncertain significance (Dec 19, 2023) | ||
10-22537249-T-C | Benign (Oct 09, 2017) | |||
10-22537255-G-T | not specified | Uncertain significance (Sep 16, 2021) | ||
10-22541831-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
10-22541839-G-C | not specified | Uncertain significance (Oct 06, 2021) | ||
10-22541861-G-T | Benign (Dec 13, 2018) | |||
10-22541914-G-T | not specified | Uncertain significance (Oct 12, 2021) | ||
10-22541923-C-G | not specified | Uncertain significance (Nov 07, 2022) | ||
10-22541928-G-A | Benign (Oct 09, 2017) | |||
10-22541933-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
10-22541950-T-C | not specified | Uncertain significance (Feb 22, 2023) | ||
10-22541988-C-A | not specified | Uncertain significance (Jun 10, 2024) | ||
10-22541993-C-G | not specified | Uncertain significance (Jul 12, 2023) | ||
10-22550154-G-A | Benign (Aug 23, 2019) | |||
10-22573343-G-A | not specified | Uncertain significance (Feb 11, 2022) | ||
10-22591649-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
10-22591745-A-T | not specified | Uncertain significance (Feb 10, 2022) | ||
10-22591760-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
10-22607917-C-T | Benign (Oct 09, 2017) | |||
10-22607998-A-C | not specified | Uncertain significance (Dec 14, 2023) | ||
10-22609676-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
10-22714185-A-C | not specified | Uncertain significance (Aug 12, 2022) | ||
10-22714199-C-A | not specified | Uncertain significance (Jul 09, 2021) | ||
10-22714263-G-T | not specified | Uncertain significance (Dec 08, 2023) | ||
10-22714296-C-G | not specified | Uncertain significance (Apr 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PIP4K2A | protein_coding | protein_coding | ENST00000376573 | 10 | 179707 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.142 | 0.858 | 125739 | 0 | 9 | 125748 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.36 | 178 | 237 | 0.752 | 0.0000130 | 2714 |
Missense in Polyphen | 35 | 75.582 | 0.46308 | 885 | ||
Synonymous | -0.598 | 102 | 94.6 | 1.08 | 0.00000595 | 730 |
Loss of Function | 2.95 | 5 | 18.8 | 0.266 | 8.88e-7 | 248 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000623 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the phosphorylation of phosphatidylinositol 5- phosphate (PtdIns5P) on the fourth hydroxyl of the myo-inositol ring, to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). May exert its function by regulating the levels of PtdIns5P, which functions in the cytosol by increasing AKT activity and in the nucleus signals through ING2. May regulate the pool of cytosolic PtdIns5P in response to the activation of tyrosine phosphorylation. May negatively regulate insulin- stimulated glucose uptake by lowering the levels of PtdIns5P. May be involved in thrombopoiesis, and the terminal maturation of megakaryocytes and regulation of their size. {ECO:0000269|PubMed:18364242}.;
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Phosphatidylinositol Phosphate Metabolism;Joubert syndrome;Regulation of Actin Cytoskeleton;G13 Signaling Pathway;D-<i>myo</i>-inositol (1,4,5)-trisphosphate biosynthesis;Signal Transduction;Gene expression (Transcription);Synthesis of PIPs in the nucleus;Generic Transcription Pathway;Metabolism of lipids;Inositol phosphate metabolism;RNA Polymerase II Transcription;PI5P Regulates TP53 Acetylation;Metabolism;D-<i>myo</i>-inositol-5-phosphate metabolism;superpathway of inositol phosphate compounds;BCR;Phosphatidylinositol phosphate metabolism;PIP3 activates AKT signaling;Synthesis of PIPs at the plasma membrane;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Negative regulation of the PI3K/AKT network;PI Metabolism;Phospholipid metabolism;Intracellular signaling by second messengers
(Consensus)
Recessive Scores
- pRec
- 0.212
Intolerance Scores
- loftool
- 0.301
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- Y
- hipred_score
- 0.748
- ghis
- 0.456
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.702
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pip4k2a
- Phenotype
- growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; neoplasm;
Zebrafish Information Network
- Gene name
- pip4k2aa
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- phospholipid metabolic process;phosphatidylinositol biosynthetic process;regulation of autophagy;regulation of phosphatidylinositol 3-kinase signaling;megakaryocyte development;phosphatidylinositol phosphorylation;positive regulation of autophagosome assembly
- Cellular component
- nucleoplasm;autophagosome;cytosol;plasma membrane
- Molecular function
- ATP binding;1-phosphatidylinositol-4-phosphate 5-kinase activity;1-phosphatidylinositol-5-phosphate 4-kinase activity;1-phosphatidylinositol-3-phosphate 4-kinase activity